Susquehanna Portfolio Strategies’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Other funds holding PROK
SCM
BL
AGP
HWAM
VCM
Susquehanna Portfolio Strategies's PROK Position: Q1 2026 in Review
Susquehanna Portfolio Strategies reduced its ProKidney (PROK) stake by 10% in Q1 2026, selling an estimated $23.5K and leaving 97,378 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #911.
Susquehanna Portfolio Strategies first reported a position in PROK in Q3 2025 and has held it in 3 quarters since. The position peaked at $347K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.
- Susquehanna Portfolio Strategies held 97,378 shares of ProKidney worth $174K as of Q1 2026.
- Susquehanna Portfolio Strategies sold 11,066 ProKidney shares in Q1 2026, an estimated $23.5K.
- ProKidney made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #911 holding.
- Susquehanna Portfolio Strategies first reported a position in ProKidney in Q3 2025 and has held it in 3 quarters since.
- Susquehanna Portfolio Strategies's ProKidney position peaked at $347K in Q3 2025.
- 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.